How modeling and simulation technology can predict and better manage immunogenicity, a key challenge for biologics drug development.
Piet van der Graaf
Advertisement
Articles by Piet van der Graaf
Advertisement
Latest Updated Articles
Addressing the Immunogenicity ChallengePublished: February 18th 2020 | Updated:
Advertisement
Advertisement
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
